2013
DOI: 10.2500/ar.2013.4.0042
|View full text |Cite
|
Sign up to set email alerts
|

Retained Drug-eluting Stents and Recalcitrant Chronic Rhinosinusitis: A Case Report

Abstract: Corticosteroids are the mainstay of treatment for refractory chronic rhinosinusitis. The off-label use of steroid-eluting stents has increasingly gained popularity in functional endoscopic sinus surgery for decreasing postoperative inflammation and synechiae formation. However, there is a paucity of data outlining the safety profile of this device despite its widespread use. This study was designed to report a newly described complication of retained drug-eluting stents from endoscopic sinus surgery for refrac… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
11
0
2

Year Published

2014
2014
2021
2021

Publication Types

Select...
7
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 15 publications
(13 citation statements)
references
References 15 publications
0
11
0
2
Order By: Relevance
“…[490,492], bevor eine Empfehlung ausgesprochen werden kann. Bei einem anderen System zur lokalen Kortisonapplikation ist eine Verletzung der Orbita beschrieben worden durch das in die Bulla ethmoidalis eingeführte Siebbeinimplantat und einmal wurde dieser Fremdkörper versehentlich belassen [493,494]. ist nicht bekannt.…”
Section: Synechien Im Mittleren Nasengang/stents Im Mittleren Nasengangunclassified
“…[490,492], bevor eine Empfehlung ausgesprochen werden kann. Bei einem anderen System zur lokalen Kortisonapplikation ist eine Verletzung der Orbita beschrieben worden durch das in die Bulla ethmoidalis eingeführte Siebbeinimplantat und einmal wurde dieser Fremdkörper versehentlich belassen [493,494]. ist nicht bekannt.…”
Section: Synechien Im Mittleren Nasengang/stents Im Mittleren Nasengangunclassified
“…1308,1311 However, these can be difficult to remove, with a case report of retained spacers leading to inflammation and infection 7 months after initial insertion. 1312,1313 There has also been a case report of orbital violation leading to pain and a permanently dilated pupil. 1314 Biodegradable drug-eluting stents offer the benefit of having both a mechanical spacer combined with precise sustained release of medication into the sinus cavity over a known period of time.…”
Section: Xd6 Surgical Principles/techniques: Drug Eluting Packingmentioning
confidence: 99%
“…No serious complications have been reported with the use of the Propel implant. Similarly, a case of foreign body reaction and granulation tissue has been reported due to retained ethmoid sinus implants (Relieva Stratus Microflow Spacers; Acclarent, Inc., Menlo Park, California, USA) left in situ for 7 months [33]. Villari et al [32] reported a case of orbital violation due to a Strutus Ethmoid nonabsorbable sinus implant (Acclarent, Inc., Menlo Park, California, USA) resulting in severe orbital pain and a permanently dilated pupil.…”
Section: Key Pointsmentioning
confidence: 98%